Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis

QR Code

Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis

Saved in:

Bibliographic Details
Main Authors:	Füvesi Judit Hanrieder Jörg Bencsik Krisztina Rajda Cecilia Kovács Krisztián S. Kaizer László Beniczky Sándor Vécsei László Bergquist Jonas
Format:	Article
Published:	MDPI AG 2012
Series:	International Journal of Molecular Sciences 13 No. 6
doi:	10.3390/ijms13067676
mtmt:	2078808
Online Access:	http://publicatio.bibl.u-szeged.hu/4056

Similar Items

Proteomics of cerebrospinal fluid for biomarker discovery in multiple sclerosis
by: Füvesi Judit, et al.
Published: (2013)

Proteomics in Multiple Sclerosis The Perspective of the Clinician /
by: Sandi Dániel, et al.
Published: (2022)

Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis
by: Szalárdy Levente, et al.
Published: (2013)

Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide y in multiple sclerosis
by: Vécsei László, et al.
Published: (1990)

Proteomic Analysis of Cerebrospinal Fluid in Alzheimer's Disease Wanted Dead or Alive /
by: Oláh Zita, et al.
Published: (2015)

Pediatric multiple sclerosis and fulminant disease course features and approaches to treatment – a case report and review of the literature /
by: Sandi Dániel, et al.
Published: (2018)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
by: Rajda Cecília, et al.
Published: (2020)

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
by: Péter Mária, et al.
Published: (2020)

Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis
by: Szalárdy Levente, et al.
Published: (2017)

Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients
by: Rajda Cecilia, et al.
Published: (2002)

The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis therapeutic implications /
by: Füvesi Judit, et al.
Published: (2012)

Studies on etiology and pathogenesis of multiple sclerosis
by: Rajda Cecília
Published: (2004)

Kynurenines and multiple sclerosis The dialogue between the immune system and the central nervous system /
by: Rajda Cecília, et al.
Published: (2015)

Szklerózis multiplex [Multiple Sclerosis]
by: Bencsik Krisztina, et al.
Published: (2023)

Familial multiple sclerosis case study of three affected siblings /
by: Bencsik Krisztina, et al.
Published: (2002)

Interferon-beta affects the tryptophan metabolism in multiple sclerosis patients
by: Amirkhani A., et al.
Published: (2005)

Rare co-occurrence of multiple sclerosis and Wilson’s disease – case report
by: Despotov Katalin, et al.
Published: (2022)

The effects of reward and punishment contingencies on decision-making in multiple sclerosis
by: Nagy Helga, et al.
Published: (2006)

Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis
by: Rajda Cecília, et al.
Published: (2017)

Multiple sclerosis
by: Farra Firas Anwar
Published: (1990)

Medicinal Chemistry of Multiple Sclerosis Focus on Cladribine /
by: Biernacki Tamás, et al.
Published: (2020)

Kynurenines in the Pathogenesis of Multiple Sclerosis Therapeutic Perspectives /
by: Biernacki Tamás, et al.
Published: (2020)

Proteomic investigation of wheat intercellular washing fluid
by: Pós Veronika
Published: (2005)

The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease Shortcomings in Prodromal Diagnosis /
by: Szalárdy Levente, et al.
Published: (2016)

Kynurenine metabolism in multiple sclerosis
by: Hartai Zsuzsanna, et al.
Published: (2005)

Monitoring the Redox Status in Multiple Sclerosis
by: Tanaka Masaru, et al.
Published: (2020)

Validation of the Fatigue Impact Scale in Hungarian patients with multiple sclerosis
by: Losonczi Erika, et al.
Published: (2011)

Multiple sclerosis to date diagnosis, epidemiology, new aspects of the pathomechanism and the therapy /
by: Bencsik Krisztina
Published: (2002)

Nonenzymatic antioxidants of blood in multiple sclerosis
by: Karg Eszter, et al.
Published: (1999)

The epidemiology of multiple sclerosis in Europe
by: Pugliatti M., et al.
Published: (2006)

Prevalence of multiple sclerosis in Csongrad County, Hungary
by: Zsíros Viktória, et al.
Published: (2014)

Fulminant Epstein-Barr virus esophagitis in an immunocompetent patient
by: Annaházi Anita, et al.
Published: (2011)

Alemtuzumabterápiával kezelt sclerosis multiplexes betegek követéses vizsgálata a szegedi sclerosis multiplex centrumban [Follow up examination of multiple sclerosis patients treated with alemtuzumab in Multiple Sclerosis Centre, Szeged]
by: Fricska-Nagy Zsanett, et al.
Published: (2022)

Long-term immunomodulatory treatment and quality of life of patients with multiple sclerosis
by: Füvesi Judit
Published: (2011)

Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
by: Nagy Helga, et al.
Published: (2013)

A sclerosis multiplex korszerű kezelése
by: Bencsik Krisztina, et al.
Published: (2003)

A relapsus-remissio kórformájú sclerosis multiplex kezelése immunglobulinnal
by: Bencsik Krisztina, et al.
Published: (2003)

RAGE Gene Polymorphisms in Patients with Multiple Sclerosis
by: Tiszlavicz Zoltán László, et al.
Published: (2009)

Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients
by: Bencsik Krisztina, et al.
Published: (2007)

APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
by: Losonczi Erika, et al.
Published: (2010)